BRND, IWEB, NVIV & Extended Watchlist

Premier Brands, Inc. BRND
-
After discovering BRND’s news with Dennis Rodman and delivering our initial alert on the stock Thursday morning, we saw this juggernaut bull its way from a low of .0043 to Friday’s high at .0359. That represented an overall move of 735% over just two trading sessions.

As we always do with such a rapid gainer, we urged caution as we remained on the lookout for a pullback. That began to occur on Friday afternoon, with the stock closing at .0115. Today, we’ll be monitoring BRND for any possible bounce opportunities. We’ll need to see it hold a minimum support level of a penny in order for us to stay interested.


ICEweb, Inc. IWEB

IWEB brought us the chance for nearly 100% in cumulative gains last week, with a 48% initial run following our first report on the stock, after which we saw roughly 45% in subsequent bounces.  This is likely to be a stock that remains on our radars for quite awhile, as we follow along with the company’s efforts to expand their cloud services business. We were informed this morning of another development involving a large sale to a prestigious client.This Morning’s PR:

STERLING, Va.–(BUSINESS WIRE)– IceWEB Storage Corporation – (OTC BB:IWEB), an award-winning Unified Data Storage appliance provider for cloud and virtual environments, as well as the highly secure, scalable IceBOX BYOD (Bring Your Own Device) Private Digital Cloud Solution, today announced that the Company secured an order from an Ivy League University for up to 5,000 users.

 The University chose an IceWEB 2200 2U IceBOX storage appliance with 4TB capacity expandable to 48TB. >>> FULL REPORT


InVivo Therapeutics Holdings Corp. NVIV

NVIV is new to our reports today, and is a stock with a very intriguing backstory. The company is currently in the process of developing technologies to treat spinal cord injuries (SCI) with unprecedented success, if early tests are any indicator.

InVivo plans to culminate these technologies into unique products it intends to bring to the medical field. These include a bio-compatible polymer “scaffolding” device which is used to treat acute SCI’s, as well as a controlled-release methylprednisolone “hydrogel” which could replace injections currently used for some SCI’s.  The products have been tested, and demonstrated to promote functional recovery following traumatic SCI’s in several test subjects including rodent and non-human primate models.

This is definitely going to be an interesting stock to follow, especially with the current chart setup. We are seeing a definite uptrend, as the RSI heads into the powerzone, and the MACD recently underwent a bullish cross, as we’ve pointed out on the chart below:

 


Side Note:
On the options trading front, we are looking at LULU $65 Calls this morning.


Extended Watchlist:
CRWE, RNN, KNDI, XOMA,
LEAP (To be acquired by AT&T for 15$ a share)
PMCM (Possible momentum carryover from last week)

 

Comments are closed.